SCHEMBL6791810

SCHEMBL6791810

COc1ccc(/C=C/C=C/C(=O)N2CCN3CCN(C(=O)/C=C/C=C/c4ccc(OC)c(OC)c4)CC3C2)cc1OC

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.59
KDM4E B2RXH2 4/20 0.58
ALDH1A1 P00352 3/20 0.58
KMT2A Q03164 3/20 0.58
TDP1 Q9NUW8 1/20 0.56
MEN1 O00255 2/20 0.49
MAOB P27338 3/20 0.49
MAOA P21397 2/20 0.49
HPGD P15428 1/20 0.47
ALOX15 P16050 1/20 0.47
MAPK1 P28482 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
HSD17B10 Q99714 1/20 0.47
BCHE P06276 1/20 0.47
ACHE P22303 1/20 0.47
TRPV1 Q8NER1 1/20 0.46
NFE2L2 Q16236 1/20 0.46
ANPEP P15144 2/20 0.46
SHMT2 P34897 1/20 0.46
MMP2 P08253 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL6787360 0.99 L3MBTL1 (0.58) L3MBTL1KDM4EALDH1A1KMT2ATDP1
SCHEMBL8318287 0.87 ALDH1A1 (0.57) L3MBTL1KDM4EALDH1A1KMT2AMEN1
Hydrochloric Acid SCHEMBL6782277 0.86 ALDH1A1 (0.56) L3MBTL1KDM4EALDH1A1KMT2AMEN1
SCHEMBL6782747 0.84 KDM4E (0.76) L3MBTL1KDM4EALDH1A1KMT2ATDP1
SCHEMBL17340509 0.83 L3MBTL1 (0.83) L3MBTL1KDM4EALDH1A1KMT2ATDP1
SCHEMBL16274617 0.82 KDM4E (0.81) L3MBTL1KDM4EALDH1A1KMT2ATDP1
SCHEMBL29738480 0.82 KDM4E (0.81) L3MBTL1KDM4EALDH1A1KMT2ATDP1
SCHEMBL14255225 0.82 KDM4E (0.81) L3MBTL1KDM4EALDH1A1KMT2ATDP1
SCHEMBL6785625 0.77 ALOX5 (0.44) KDM4EALDH1A1TDP1MAOBMAOA
Hydrochloric Acid SCHEMBL6787082 0.76 ALOX5 (0.43) KDM4EALDH1A1TDP1MAOBMAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6828316-B2 Antiallergens KOWA CO., LTD. (JP) 2004-12-07 US disclosed
US-20020042414-A1 Diamide compound and medicine containing the same KOWA CO., LTD. (JP) 2002-04-11 US disclosed
US-6340682-B1 FOR THERAPY OF ALLERGIC IMMUNOLOGICAL DISEASE IS SELECTED FROM ASTHMA, ALLERGIC RHINITIS, INFLAMMATORY LARGE BOWEL DISEASE OR CONTACT DERMATITIS KOWA CO., LTD. (JP) 2002-01-22 US disclosed
EP-0926138-A1 DIAMIDE COMPOUNDS AND DRUGS CONTAINING THE SAME KOWA CO. LTD. (JP) 1999-06-30 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020042414-A1 Diamide compound and medicine containing the same HRH4, HRH2, HRH1 L3MBTL1 3376/4885KDM4E 562/4885ALDH1A1 836/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.